Patents by Inventor Bruce Duane Coate

Bruce Duane Coate has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pimavanserin alone or in combination for use in the treatment of Alzheimer's disease psychosis
    Patent number: 11464768
    Abstract: Methods for the treatment of Alzheimer's disease psychosis, or a symptom thereof, comprising administering pimavanserin. Also provided herein are methods for the treatment of delusions and/or hallucinations in a human with dementia comprising administering pimavanserin, or a pharmaceutically acceptable salt thereof. Also provided herein are methods for reducing NPI-NH score in a human with Alzheimer's Disease comprising administering pimavanserin, or a pharmaceutically acceptable salt thereof. Also provided herein are methods for reducing agitated behavior or aggressive behavior in a human with dementia comprising administering pimavanserin, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: December 14, 2017
    Date of Patent: October 11, 2022
    Assignee: ACADIA Pharmaceuticals Inc.
    Inventors: Bruce Duane Coate, James Randall Owen, Mark Donald Knowles, Srdjan R. Stankovic, James M. Youakim
  • PIMAVANSERIN ALONE OR IN COMBINATION FOR USE IN THE TREATMENT OF ALZHEIMER'S DISEASE PSYCHOSIS
    Publication number: 20200237739
    Abstract: Methods for the treatment of Alzheimer's disease psychosis, or a symptom thereof, comprising administering pimavanserin. Also provided herein are methods for the treatment of delusions and/or hallucinations in a human with dementia comprising administering pimavanserin, or a pharmaceutically acceptable salt thereof. Also provided herein are methods for reducing NPI-NH score in a human with Alzheimer's Disease comprising administering pimavanserin, or a pharmaceutically acceptable salt thereof. Also provided herein are methods for reducing agitated behavior or aggressive behavior in a human with dementia comprising administering pimavanserin, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: December 14, 2017
    Publication date: July 30, 2020
    Inventors: Bruce Duane Coate, James Randall Owen, Mark Donald Knowles, Srdjan R. Stankovic, James M. Youakim